680 filings
Page 10 of 34
CORRESP
z6n0fsn06clg ne
7 Jul 17
Correspondence with SEC
12:00am
UPLOAD
sv1whjp50
7 Jul 17
Letter from SEC
12:00am
UPLOAD
jaru1yw01jqjgoi2d3t
6 Jul 17
Letter from SEC
12:00am
8-K
q2bg yxa556qbkgauust
5 Jun 17
Other Events
12:00am
8-K
dbeu47o9rove ofu04
2 Jun 17
Departure of Directors or Certain Officers
12:00am
S-8
p1l8wsl7a
2 Jun 17
Registration of securities for employees
12:00am
8-K
9ax8axa6 cggwk7
30 May 17
Other Events
12:00am
8-K
f6tp0ta 57d6898o9t6
25 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
a3wnw
8 May 17
Dynavax Reports First Quarter 2017 Financial Results
12:00am
EFFECT
e8fein5f
26 Apr 17
Notice of effectiveness
12:00am
CORRESP
9aiaj
24 Apr 17
Correspondence with SEC
12:00am
8-K
la31eg7
3 Apr 17
Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B
12:00am
POS AM
260psvbx
17 Mar 17
Prospectus update (post-effective amendment)
12:00am
8-K
nf61ax5f3r38c42f
13 Mar 17
Dynavax Reports Fourth Quarter and Year End 2016 Financial Results and Company Update
12:00am